who medicines strategy - libdoc.who.int - World Health Organization

More documents

Recommendations

Info

WHO MEDICINES STRATEGY 2004-2007 | 136WORLD HEALTH ORGANIZATION> >HQ AFRO COUNTRY OFFICES>>>>COUNTRIESMINISTRIES OF HEALTH>>PARTNERS IN COUNTRY SUPPORT>WHO OPERATIONALPARTNERSUNAIDS, bilateralcooperation,public interestNGOS in health,UNDP, UNFPA,UNCTADWHO SCIENTIFICPARTNERSWHOCollaboratingCentres inpharmaceuticals,universities,research centres,internationalhealthprofessionals'associationsWHO STRATEGICPARTNERSWorld Bank anddevelopmentbanks,pharmaceuticalindustry, WTO,WIPO, EUWorking in partnership – supporters andco-workersAll available resources must be called upon andwell coordinated to promote appropriate andeffective national medicines policies, access,quality and safety, and appropriate use of essentialmedicines. EDM expertise and resources aremaximized through close collaboration and coordinationwithin EDM and between EDM and itspartners. EDM partners in country support includepublic and private sector businesses and researchinstitutes, CSOs, and global entities.Efforts to strengthen partnerships within EDMteams and departments and between EDMheadquarters and regional and country offices,and to build operational, scientific, and strategicpartnerships with others are key to fulfillingWHO’s goals in pharmaceuticals.It is in coordination withoperational partners that WHOsupports countries to develop andsustain effective pharmaceuticalsectors, including access toand appropriate use of qualitymedicines.It is with strategic partners thatWHO can promote improvementsin global public health.It is with the expertise of scientificpartners that WHO can providethe level of specialist technicaladvice requested by countries.More than 40 WHO CollaboratingCentres now work with WHO onmedicine priorities.
IMPLEMENTING THE STRATEGY | 137Examples of such partnerships in the past threeyears include:> The development in 2002 of the Handbookon Access to HIV/AIDS Treatment inpartnership with the HIV/AIDS Alliance andUNAIDS.> The project to prequalify manufacturers ofARVs, including generic producers, based inWHO and operating in collaboration with theIPC.> In 1995-2002, the development of acomputerized system for registration,involving original work in Tunisia Pharmacyand Medicines Directorate and subsequentdevelopmental work in the EMEA.Working in line with WHO Strategy– links in the knowledge chain buildingstrengthIn turning to WHO for expert advice onmedicines, countries may request data andstatistics concerning health information andadvice on a wide range of health issues or adviceon new and innovative approaches to longstandingor newly emerging health problems.WHO’s response will be in line with the corporatestrategy of fulfilling its mandate and drawingon the core function to create, synthesize, anddisseminate knowledge through a series of relatedapproaches (Figure 30)> A collaborative project with HAI Africa toimprove the involvement of civil society inpolicy development and implementation incountries in the region.> Collaboration with four WHO CollaboratingCentres to develop materials in relation toTRIPS and to monitor the impact of TRIPS andother trade agreements on public health andaccess to essential medicines.
Page 10 and 11:
WHO MEDICINES STRATEGY 2004-2007 |x
Page 12 and 13:
WHO MEDICINES STRATEGY 2004-2007 |x
Page 14 and 15:
WHO MEDICINES STRATEGY 2004-2007 |
Page 23:
MEDICINESAND PUBLIC HEALTH
Page 26 and 27:
Page 28 and 29:
Page 30 and 31:
Page 32 and 33:
Page 34 and 35:
Page 36 and 37:
Page 38 and 39:
Page 40 and 41:
Page 42 and 43:
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
Page 50 and 51:
Page 52 and 53:
Page 54 and 55:
Page 56 and 57:
Page 58 and 59:
Page 60 and 61:
Page 62 and 63:
Page 64 and 65:
Page 66 and 67:
Page 68 and 69:
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
Page 98 and 99: WHO MEDICINES STRATEGY 2004-2007 |
Page 157 and 158: REFERENCES
Page 159 and 160: REFERENCES | 1471Annual report 2000
Page 161 and 162: REFERENCES | 14912 th Model List of
show all

who medicines strategy - libdoc.who.int - World Health Organization

Create successful ePaper yourself

Delete template?

Save as template?